Eye
Medicines for Amaurosis fugax
A temporary loss of vision in one eye, often described as a curtain coming down, which usually signals a warning of stroke risk and needs urgent assessment.
Education and reference only. This explains which medicines are used and why, in plain language — it deliberately contains no doses and is not a substitute for advice from your doctor or pharmacist. Always discuss your own treatment with a qualified clinician, and check the BNF and the product labelling for prescribing detail.
Quick answer
What is Amaurosis fugax?
Amaurosis fugax means a temporary (transient) loss of vision, usually in one eye, that comes on suddenly and then recovers, often within minutes. It is classically described as a curtain or shade coming down (or across) the vision of one eye, which then lifts and the vision returns to normal.
- How it is treated: Amaurosis fugax should be treated as a "mini-stroke" (TIA) and needs urgent medical assessment, even though the vision has recovered — because the priority is to identify and reduce the high risk of a future stroke or permanent vision loss.
- Self-care: After urgent assessment, reducing cardiovascular risk is central — managing blood pressure, cholesterol and diabetes, not smoking, staying active, a healthy diet, and taking prescribed medicines (such as antiplatelets) — to lower the risk of a stroke.
- When to seek help: Seek urgent medical assessment (as for a mini-stroke/TIA — call 999 or go to A&E) for a temporary loss of vision in one eye (such as a curtain coming down that then lifts), even though the vision has recovered — it is a serious warning of stroke risk needing prompt assessment and treatment.
What it is
Amaurosis fugax means a temporary (transient) loss of vision, usually in one eye, that comes on suddenly and then recovers, often within minutes. It is classically described as a curtain or shade coming down (or across) the vision of one eye, which then lifts and the vision returns to normal. It happens because the blood supply to the retina (or the eye or its nerve) is briefly interrupted — most commonly by a small clot or piece of debris temporarily blocking the artery to the eye, often coming from narrowed arteries in the neck (the carotid arteries) or from the heart. Its great importance is that amaurosis fugax is a form of "mini-stroke" (transient ischaemic attack, TIA) affecting the eye, and is therefore a serious warning sign that the person is at high risk of a full stroke (in the brain) or a permanent loss of vision in the near future. So, although the vision itself recovers and the episode may seem to resolve completely, amaurosis fugax must not be ignored — it needs urgent assessment and treatment to reduce the risk of a stroke, just as any TIA would. In older people, it can also be a warning of giant cell arteritis, another urgent condition. Recognising it as a warning sign and acting quickly is key.
How it is treated
Amaurosis fugax should be treated as a "mini-stroke" (TIA) and needs urgent medical assessment, even though the vision has recovered — because the priority is to identify and reduce the high risk of a future stroke or permanent vision loss. Urgent assessment (via TIA/stroke services) involves investigating the cause — including scans of the neck (carotid) arteries and the heart, and checking for risk factors such as an irregular heart rhythm (atrial fibrillation), high blood pressure, diabetes, and high cholesterol — and starting treatment promptly to reduce the risk. This treatment typically includes medicines to reduce the risk of clots (such as antiplatelet medicines) and managing the risk factors, and, where significant narrowing of a neck artery is found, a procedure to treat it may be considered to prevent a stroke. In older people, giant cell arteritis is urgently excluded and treated if suspected, as it can threaten the other eye. Reducing overall cardiovascular risk (blood pressure, cholesterol, diabetes, stopping smoking) is important long-term. The vital message is that amaurosis fugax, though the vision recovers, is an urgent warning sign of stroke risk that must be assessed immediately — prompt assessment and treatment can substantially reduce the risk of a future stroke.
For this condition, these medicines
Medicine classes used for Amaurosis fugax
Each links to a full, dose-free guide — what it is, how it works, who can and cannot use it, side effects, interactions and FAQs.
Beyond medication
Lifestyle and self-care
After urgent assessment, reducing cardiovascular risk is central — managing blood pressure, cholesterol and diabetes, not smoking, staying active, a healthy diet, and taking prescribed medicines (such as antiplatelets) — to lower the risk of a stroke. The key immediate action is urgent medical assessment, treating it like a mini-stroke.
When to get help
When to see a doctor
Seek urgent medical assessment (as for a mini-stroke/TIA — call 999 or go to A&E) for a temporary loss of vision in one eye (such as a curtain coming down that then lifts), even though the vision has recovered — it is a serious warning of stroke risk needing prompt assessment and treatment.
Not sure how urgent it is? It is always OK to call NHS 111 for advice, day or night.
Answers
Amaurosis fugax: frequently asked questions
What does amaurosis fugax mean?
It is a temporary loss of vision, usually in one eye, often described as a curtain coming down that then lifts, caused by a brief interruption of the blood supply to the eye — often from a small clot or debris. The vision recovers, but it is an important warning sign.
Why is amaurosis fugax serious if the vision recovers?
Because it is a form of "mini-stroke" (TIA) affecting the eye, and a serious warning that the person is at high risk of a full stroke or permanent vision loss in the near future. It needs urgent assessment and treatment to reduce that risk, just like any TIA.
Sources
Where this is drawn from
- NHS — Transient ischaemic attack (TIA)
- Royal College of Ophthalmologists guidance
Related conditions
Building a patient-information or formulary resource?
We create evidence-led, dose-free clinical references and decision aids for teams.